Endpoints News 生物医药· ENDPOINTS·· 2026-10-19AI 评分23
EyePoint III 期试验失败及礼来中国药物递送协议
EyePoint's Phase 3 failure; Lilly's China drug delivery deal
AI 导读
总部位于马萨诸塞州 WaterTown 的生物科技公司 EyePoint 宣布其 III 期试验失败。受此影响,该公司将对员工进行大规模裁员。同一天,礼来(Lilly)也与中国某公司达成了药物递送领域的合作协议。
正文
Plus news about Longwood’s next fund and Ryzumvi’s label expansion.
EyePoint drug fails, biotech halves staff: The Watertown, MA-based biotech is letting go of
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news